Total Payments
$2,491
2024 Payments
$1,006
Companies
25
Transactions
104
Medicare Patients
1,193
Medicare Billing
$87,671
Payment Breakdown by Category
Food & Beverage$2,376 (95.4%)
Education$115.26 (4.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,376 | 102 | 95.4% |
| Education | $115.26 | 2 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $562.41 | 41 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $289.14 | 10 | $0 (2024) |
| Celgene Corporation | $250.95 | 2 | $0 (2017) |
| Dermavant Sciences, Inc. | $185.00 | 8 | $0 (2024) |
| Amgen Inc. | $163.48 | 6 | $0 (2024) |
| DUSA Pharmaceuticals, Inc. | $122.03 | 1 | $0 (2018) |
| Promius Pharma LLC | $116.06 | 1 | $0 (2017) |
| LEO Pharma Inc. | $102.69 | 5 | $0 (2024) |
| Janssen Biotech, Inc. | $99.99 | 1 | $0 (2023) |
| Arcutis Biotherapeutics, Inc. | $65.79 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,006 | 50 | ABBVIE INC. ($267.78) |
| 2023 | $607.92 | 29 | ABBVIE INC. ($152.55) |
| 2022 | $151.37 | 14 | ABBVIE INC. ($127.56) |
| 2021 | $29.69 | 2 | Pierre Fabre Pharmaceuticals, Inc. ($15.17) |
| 2018 | $156.42 | 3 | DUSA Pharmaceuticals, Inc. ($122.03) |
| 2017 | $539.51 | 6 | Celgene Corporation ($250.95) |
All Payment Transactions
104 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Dermatology | ||||||
| 11/27/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.81 | General |
| Category: Immunology | ||||||
| 11/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.41 | General |
| 11/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $28.47 | General |
| Category: Inflammation | ||||||
| 10/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.51 | General |
| Category: Immunology | ||||||
| 09/11/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Dermatology | ||||||
| 08/27/2024 | Krystal Biotech Inc | VYJUVEK (Drug) | Food and Beverage | In-kind items and services | $29.37 | General |
| Category: DERMATOLOGY | ||||||
| 08/22/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: DERMATOLOGY | ||||||
| 08/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $30.39 | General |
| Category: IMMUNOLOGY | ||||||
| 08/13/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: Dermatology | ||||||
| 08/09/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: DERMATOLOGY | ||||||
| 08/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $34.47 | General |
| Category: IMMUNOLOGY | ||||||
| 07/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: IMMUNOLOGY | ||||||
| 07/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.90 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 577 | 1,108 | $106,974 | $44,143 |
| 2020 | 10 | 616 | 900 | $190,962 | $43,528 |
Total Patients
1,193
Total Services
2,008
Medicare Billing
$87,671
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 109 | 161 | $17,710 | $11,436 | 64.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 71 | 88 | $19,800 | $8,270 | 41.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 64 | 64 | $12,480 | $4,972 | 39.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 56 | 63 | $11,970 | $4,654 | 38.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 88 | 104 | $18,200 | $3,947 | 21.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 77 | 459 | $9,180 | $2,733 | 29.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 17 | 19 | $5,700 | $2,634 | 46.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 25 | 38 | $4,180 | $1,691 | 40.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 14 | $2,310 | $1,417 | 61.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 21 | $1,449 | $1,022 | 70.5% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 14 | 23 | $2,300 | $737.44 | 32.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 11 | 11 | $1,265 | $592.50 | 46.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 16 | 43 | $430.00 | $36.56 | 8.5% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 69 | 97 | $42,583 | $8,713 | 20.5% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 82 | 95 | $29,070 | $6,832 | 23.5% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 63 | 63 | $19,530 | $5,359 | 27.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 61 | 86 | $17,888 | $4,694 | 26.2% |
| 17000 | Destruction of skin growth | Office | 2020 | 86 | 131 | $26,593 | $4,490 | 16.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 44 | 51 | $15,759 | $4,331 | 27.5% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 83 | 83 | $17,928 | $4,309 | 24.0% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2020 | 41 | 67 | $13,802 | $3,111 | 22.5% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 73 | 211 | $5,697 | $1,105 | 19.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 14 | 16 | $2,112 | $584.13 | 27.7% |
About Dr. Lauren Keller, DO
Dr. Lauren Keller, DO is a Dermatology healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2012. The National Provider Identifier (NPI) number assigned to this provider is 1477818938.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lauren Keller, DO has received a total of $2,491 in payments from pharmaceutical and medical device companies, with $1,006 received in 2024. These payments were reported across 104 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,376).
As a Medicare-enrolled provider, Keller has provided services to 1,193 Medicare beneficiaries, totaling 2,008 services with total Medicare billing of $87,671. Data is available for 2 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Sacramento, CA
- Active Since 07/11/2012
- Last Updated 04/23/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1477818938
Products in Payments
- Otezla (Drug) $364.43
- RINVOQ (Biological) $282.35
- SKYRIZI (Biological) $280.06
- VTAMA (Drug) $185.00
- COSENTYX (Drug) $166.64
- COSENTYX (Biological) $122.50
- Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution, 20% (Drug) $122.03
- Promiseb Complete (Device) $116.06
- ADBRY (Biological) $102.69
- TREMFYA (Drug) $99.99
- DUPIXENT (Biological) $65.43
- Zoryve (Drug) $53.09
- Sotyktu (Drug) $51.60
- VYJUVEK (Drug) $51.50
- Poteligeo (Drug) $50.32
- Enbrel (Biological) $50.00
- JUBLIA (Drug) $46.84
- ILUMYA (Biological) $45.43
- HEMANGEOL (Drug) $44.16
- TALTZ (Drug) $34.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Sacramento
Dr. Raja Sivamani, M.d., M.s., A.h.e, M.D., M.S., A.H.E
Dermatology — Payments: $1.3M
Dermatology $1.3M
Dr. Emil Tanghetti, M.d, M.D
Dermatology — Payments: $1.0M
Dermatology $1.0M
Jacqueline Calkin, M.d, M.D
Dermatology — Payments: $130,291
Dermatology $130,291
Dr. Emanual Maverakis, M.d, M.D
Dermatology — Payments: $52,284
Dermatology $52,284
Alison Boudreaux, M.d, M.D
Dermatology — Payments: $46,728
Dermatology $46,728
Mirza Alikhan, Md, MD
Dermatology — Payments: $30,111
Dermatology $30,111